Driven by the escalating costs of both health care delivery and research, the concept of health care value is of increasing interest to both payers and providers. In this respect, the randomized controlled trial (RCT) often falls short. RCTs do not always
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/03/14/private-payer-participation-in-coverage-with-evidence-development-a-case-study/
Posted
Mar 14 2017, 08:00 AM
by
Health Affairs BlogHealth Affairs Blog
Filed under: Medicare, Featured, Insurance and Coverage, Organization and Delivery, Costs and Spending, Women's Health, PCORI, coverage with evidence development, Drugs and Medical Innovation, Wisdom Study, Blue Shield of California, comparative effectiveness studies